Home/Recalls/FDA-D-0444-2026
FDA DrugsClass II

Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx onl...

Published: April 15, 2026Recall ID: D-0444-2026Category: drugsCountry: US

Reason for Recall / Hazard

Failed Dissolution Specifications

Product Description & Identification

Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLC, Morgantown, WV 06506, U.S.A, Made in Ireland, NDC 58151-506-91

Additional Source Details

FieldValue
CityCanonsburg
StatePA
Openfda › Nui › 1N0000175694
Openfda › Nui › 2M0002356
Openfda › Upc › 10358151506910
Openfda › Upc › 20358151504916
Openfda › Upc › 30358151503919
Openfda › Upc › 40358151505913
Openfda › UniiYU55MQ3IZY
Openfda › RouteORAL
Openfda › Rxcui › 1433798
Openfda › Rxcui › 2433799
Openfda › Rxcui › 3433800
Openfda › Rxcui › 4433801
Openfda › Rxcui › 5687022
Openfda › Rxcui › 6687023
Openfda › Rxcui › 7687024
Openfda › Rxcui › 8687025
Openfda › Spl id7ceb0a8d-f766-4806-a289-652080edf4a3
Openfda › Brand nameXANAX
Openfda › Spl set idc8990714-c2f5-4b0c-9f1c-91d77156d962
Openfda › Package ndc › 158151-503-91
Openfda › Package ndc › 258151-504-91
Openfda › Package ndc › 358151-505-91
Openfda › Package ndc › 458151-506-91
Openfda › Product ndc › 158151-503
Openfda › Product ndc › 258151-504
Openfda › Product ndc › 358151-505
Openfda › Product ndc › 458151-506
Openfda › Generic nameALPRAZOLAM
Openfda › Product typeHUMAN PRESCRIPTION DRUG
Openfda › Pharm class csBenzodiazepines [CS]
Openfda › Substance nameALPRAZOLAM
Openfda › Pharm class epcBenzodiazepine [EPC]
Openfda › Manufacturer nameViatris Specialty LLC
Openfda › Application numberNDA021434
Openfda › Is original packagertrue
Event id98613
Address 11000 Mylan Blvd
Code infoLot# 8177156, Exp Date: 02/28/2027
Postal code15317-5853
Report date20260415
Product typeDrugs
Reason for recallFailed Dissolution Specifications
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20260317
Initial firm notificationLetter
Center classification date20260408

Overview

  • Recalling FirmViatris, Inc.
  • StatusOngoing
  • Risk LevelClass II
  • DistributionUS Nationwide.
Official Agency Alert